SHARESIFT
Healthcare · data ~15-min delayed
156.38 AUD -2.92%
| Price | 156.38 AUD |
| Day change | -2.92% |
| Market cap | 16.34B |
| 52-week range | 107.75 – 316.26 |
| P/E (trailing) | 61.8 |
| Dividend yield | 0.44% |
| Payout ratio | 24.45% |
| Return on equity | 74.97% |
| Debt / equity | 0% |
| Beta | 0.58 |
| Sector | Healthcare |
| Value score | 35 / 100 |
How the value score is calculated: 13 published tests, weighted to 100.
Pro Medicus Limited (PME.AX) scores 35/100 on this site's value model, in the lower band: most of the valuation measures it checks sit on the richer side. It trades at 61.8 times trailing earnings and is classified in Healthcare. The dividend yield is 0.44%, paid from 24% of earnings. Return on equity is 75%, with debt at 0% of equity. On its filings it passes 5 of the nine Piotroski checks, a mixed picture. Its Altman Z-Score places it in the safe zone. These are automated readings of reported figures, not a recommendation.
Piotroski F-Score 5 / 9 — nine pass/fail checks on profitability, leverage and efficiency, comparing the latest financial year with the one before.
Altman Z-Score 64.66 — Safe zone.
Updated · prices ~15-min delayed, fundamentals as last reported
Open full interactive analysis →See how it ranks: ASX stocks by value score
Value scoring · Piotroski F-Score · Altman Z · technicals · dividends — free, no sign-up.